网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
肥胖和代谢综合征的联合作用与糖尿病的发病风险研究
作者:胡永峰1  李强2  汪树锋1  张敏哲3  郑淼冰4  何启强3  卢高磊3 
单位:1. 武汉市新洲区疾病预防控制中心, 湖北 武汉 431400;
2. 武昌理工学院 护理学院, 湖北 武汉 430071;
3. 武汉大学 公共卫生学院, 湖北 武汉 430071;
4. 澳大利亚迪肯大学 营养与运动学院, 维多利亚州 墨尔本-伯伍德 3216
关键词:肥胖 代谢综合征 联合作用 糖尿病 队列研究 
分类号:R587
出版年·卷·期(页码):2022·50·第九期(1124-1128)
摘要:

目的:探讨肥胖和代谢综合征的联合作用与中老年人群的糖尿病发病风险,为我国中老年人群糖尿病防治提供科学依据。方法:本研究为前瞻性队列研究,选用2011至2015年中国健康与养老追踪调查(CHARLS)数据。将研究对象根据体重和代谢状态分为代谢正常非超重/肥胖组、代谢正常超重/肥胖组、代谢异常/非超重肥胖组和代谢异常超重肥胖组。采用多因素Logistic回归模型评估肥胖、代谢综合征以及两者联合作用与糖尿病发病的关联性。结果:本研究共纳入4 233名研究对象,平均年龄(58.94±8.76)岁;在为期4年的随访中,共有502人(11.86%)发生糖尿病。在调整性别、年龄、学历等混杂因素后,与代谢正常非超重/肥胖组相比,代谢异常超重/肥胖组显著增加了发生糖尿病风险(OR=4.15,95%CI 3.24~5.30)。结论:超重/肥胖和代谢综合征的联合作用会显著增加中老年人发生糖尿病的风险。

Objective: To investigate the combined effects of obesity and metabolic syndrome on the risk of diabetes in middle-aged and elderly populations, and to provide a scientific basis for the prevention and treatment of diabetes in middle-aged and elderly populations in China. Methods: This study was a prospective cohort study, and data from the China Health and Retirement Longitudinal Study(CHARLS) 2011-2015 were selected for participation. The subjects were divided into normal metabolic non-overweight/obese group, normal metabolic overweight/obese group, abnormal metabolic/non-overweight obese group and abnormal metabolic overweight/obese group according to the body weight and metabolic status. Multifactorial Logistic regression models were used to assess the association between obesity, metabolic syndrome, and the combined effect of both on the development of diabetes mellitus. Results: A total of 4 233 subjects with a mean age of(58.94±8.76) years were included in this study; a total of 502(11.86%) developed diabetes during a 4-year follow-up. After adjusting for confounding factors such as sex, age, and education, the abnormal metabolic overweight/obese group had a significantly increased risk of developing diabetes compared with the normal metabolic non-overweight/obese group(OR=4.15,95%CI 3.24-5.30). Conclusion: The combined effect of overweight/obesity and metabolic syndrome significantly increases the risk of developing diabetes mellitus in middle-aged and older adults.

参考文献:

[1] 郑燕蓉, 林莉, 毛月.老年慢病共病人群中肌肉减少症患病情况研究[J].现代医学, 2022, 50(5):618-623.
[2] 健康中国行动推进委员会.健康中国行动(2019-2030年):总体要求、重大行动及主要指标[J].中国循环杂志, 2019, 34(9):846-858.
[3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(上)[J].中国实用内科杂志, 2021, 41(8):668-695.
[4] 宁光.中国糖尿病防治的现状及展望[J].中国科学(生命科学), 2018, 48(8):810-811.
[5] 常文静, 蔡佳宇, 蔡辉.脂肪细胞因子、代谢综合征与风湿性疾病[J].现代医学, 2015, 43(2):256-262.
[6] SUNG K C, LEE M Y, KIM Y H, et al.Obesity and incidence of diabetes:effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver[J].Atherosclerosis, 2018, 275:50-57.
[7] XU S, MING J, JIA A, et al.Normal weight obesity and the risk of diabetes in Chinese people:a 9-year population-based cohort study[J].Sci Rep, 2021, 11(1):6090.
[8] LOW S, KHOO K C J, WANG J, et al.Development of a metabolic syndrome severity score and its association with incident diabetes in an Asian population-results from a longitudinal cohort in Singapore[J].Endocrine, 2019, 65(1):73-80.
[9] VIJAN S.Type 2 diabetes[J].Ann Intern Med, 2020, 172(10):705.
[10] ZHAO Y, HU Y, SMITH J P, et al.Cohort profile:the China Health and Retirement Longitudinal Study(CHARLS)[J].Int J Epidemiol, 2014, 43(1):61-68.
[11] 中国超重肥胖医学营养治疗专家共识编写委员会.中国超重/肥胖医学营养治疗专家共识(2016年版)[J].糖尿病天地(临床), 2016, 10(10):451-455.
[12] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(下)[J].中国实用内科杂志, 2021, 41(9):757-784.
[13] WEI Y, WANG J, HAN X, et al.Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population[J].Diabetes Metab Res Rev, 2020, 36(1):e3202.
[14] SONG Z, GAO M, LV J, et al.Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults:the China Kadoorie Biobank[J].Eur J Endocrinol, 2022, 186(2):233-244.
[15] JANGHORBANI M, SALAMAT M R, AMINI M, et al.Risk of diabetes according to the metabolic health status and degree of obesity[J].Diabetes Metab Syndr, 2017, 11(Suppl 1):S439-S444.
[16] HUDISH L I, REUSCH J E, SUSSEL L.β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes[J].J Clin Invest, 2019, 129(10):4001-4008.
[17] BARKAS F, LIAMIS G, ELISAF M, et al.Metabolically healthy obesity and risk of incident type 2 diabetes in 1077 statin-treated individuals:a six-year retrospective study[J].Eur J Prev Cardiol, 2020, 27(19):2341-2344.
[18] ZHU X, HU J, GUO H, et al.Effect of metabolic health and obesity phenotype on risk of diabetes mellitus:a population-based longitudinal study[J].Diabetes Metab Syndr Obes, 2021, 14:3485-3498.
[19] NATARAJAN H, SHANTHI RANI C S, KRISHNA KUMAR D, et al.Future risk of diabetes among Indians with metabolic and phenotypic obesity:results from the 10-year follow-up of the Chennai Urban Rural Epidemiology Study(CURES-158)[J].Acta Diabetol, 2021, 58(8):1051-1058.
[20] YEH T L, HSU H Y, TSAI M C, et al.Association between metabolically healthy obesity/overweight and cardiovascular disease risk:a representative cohort study in Taiwan[J].PLoS One, 2021, 16(2):e0246378.
[21] WANG B, ZHANG M, WANG S, et al.Dynamic status of metabolically healthy overweight/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus:a cohort study of a rural adult Chinese population[J].Obes Res Clin Pract, 2018, 12(1):61-71.
[22] SAXTON S N, CLARK B J, WITHERS S B, et al.Mechanistic links between obesity, diabetes, and blood pressure:role of perivascular adipose tissue[J].Physiol Rev, 2019, 99(4):1701-1763.
[23] ANTONOPOULOS A S, MARGARITISM, COUTINHO P, et al.Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall:the regulatory role of perivascular adipose tissue[J].Diabetes, 2015, 64(6):2207-2219.
[24] KASSI E, PERVANIDOU P, KALTSAS G, et al.Metabolic syndrome:definitions and controversies[J].BMC Med, 2011, 9:48.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 601143 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541